VIGL: Vigil Neuroscience Company Short-Term Debt
The stable operation of computing centers and laboratories, combined with optimized biomaterial delivery routes, minimizes operational disruption risks for Vigil Neuroscience (VIGL). This chart reflects a price trend demonstrating short-term debt dynamics, which currently stands at 0.00. The company's financial model relies on the commercialization of innovative means for brain cell regeneration across various pathologies.
Analytical breakdowns for Vigil Neuroscience
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Vigil Neuroscience|VIGL - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Vigil Neuro|VIGL - Company Total Debt Obligations|Debt to Book Capitalization Ratio Vigil Neuroscience, Inc.|VIGL - Company Long-Term Debt|Company Current Liabilities Vigil Neuroscience|Quick Liquidity vigilneuro.com
- earnings and valuation multiples indicators:
Fundamental company analysis:VIGL - vigilneuro.com
The specifics of the biotechnology sector require Vigil Neuroscience (VIGL) to maintain significant capital to complete clinical trials, making the control of liabilities critically important. This metric aggregates all financial obligations with a maturity horizon of up to one year, reflecting current liquidity and the risk of funding shortages. By analyzing the level of short-term loans, an investor assesses the company's resilience to macro shocks and its ability to fund development without the emergency procurement of expensive debt.
Competitor analysis for Vigil Neuroscience
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|Company Short-Term Debt XENE|Company Short-Term Debts VKTX|Short-Term Debt Volume Supernus Pharmaceuticals, Inc.|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Short-Term Indebtedness Denali Corp|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt Volume biohavenpharma.com BHVN|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|TRVI (Trevi Therapeutics Inc) - Company Short-Term Debt|Company Current Liabilities PRAX|AVXL: Company Short-Term Loans and Borrowings|Company Short-Term Debt CeriBell, Inc. (CBLL)|Prothena Corporation plc - Company Short-Term Indebtedness|Company Short-Term Debts ALEC (Alector)|Annexon Biosciences (ANNX) - Short-Term Debt|OMER: Company Current Liabilities|NGNE - Company Short-Term Debts|AC Immune (ACIU) - Company Short-Term Debt|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Neumora Therapeutics, Inc.|Short-Term Debt Scilex Holding SCLX|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|Short-Term Debt Volume alphacognition.com|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|IKT - Company Current Liabilities|Cassava Sciences - Company Short-Term Debts|Short-Term Debt Volume Assertio Holdings, Inc. ASRT|COYA: Company Short-Term Debts|Short-Term Debt Vistagen (VTGN)|Company Short-Term Debt Ovid Therapeutics Inc|Company Short-Term Indebtedness ABOS (acumenpharm.com)|Company Short-Term Debts CRVO|Company Current Liabilities alteritytherapeutics.com ATHE|Company Short-Term Debts CLNN (Clene)|PepGen Inc (PEPG) - Short-Term Debt|JUNS: Company Current Liabilities|RLMD: Company Short-Term Debt|ANVS: Company Short-Term Debts|GRCE - Short-Term Debt Volume|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|KLTO - Short-Term Indebtedness|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|Company Short-Term Debt RVPH (revivapharma.com)|Company Short-Term Debt MetaVia MTVA|NRXS: Company Short-Term Indebtedness|Helius Medical Technologies Inc. - Company Short-Term Debts|Short-Term Debt Passage Bio, Inc.|NEUP (bionomics.com.au) - Company Current Liabilities|minervaneurosciences.com (NERV) - Company Short-Term Debts|Company Short-Term Debt Athira Pharma|ADXN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|CYCN - Short-Term Debt|Protagenic Therapeutics, Inc. - Company Current Liabilities|Pasithea Therapeutics Corp - Company Short-Term Debt|Cortigent Medical - Company Short-Term Debts|Short-Term Debt Volume Avenue Therapeutics Inc. ATXI|BCLI: Company Short-Term Debts|Short-Term Indebtedness Cara Therapeutics Inc CARA|CHRO (Chromocell Therapeutics) - Company Short-Term Debts|Eliem (ELYM) - Short-Term Debt Volume|Company Short-Term Debt Intra-Cellular Therapies (ITCI)|Company Short-Term Debt LBPH (Longboard Pharmaceuticals Inc)|Marinus - Company Current Liabilities|Company Short-Term Loans and Borrowings NKGN|NRBO - Company Short-Term Debt|SAGE (sagerx.com) - Company Short-Term Indebtedness|SNPX: Company Short-Term Debts|Short-Term Debt Trevena Inc. (TRVN)|Company Current Liabilities WENA|Company Short-Term Debts Cerevel Corp